Cancer drugmaker Seattle Genetics raises $575 million in stock offering by James Thorne on July 24, 2019July 26, 2019 at 10:49 am Seattle Genetics sold more than 8 million shares in a stock offering that brought in $575 million for the company before expenses and commissions. The Bothell, Wash.-based drugmaker said the… Read More